Clinical Trials Browser

Phase 3 × OTHER × epratuzumab × Clear all

NCT01802814 2024-02-09

International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010

Phase 3 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma